Huang Xinghua, Ji Guoqing, Wu Yanhua, Wan Bo, Yu Long
The State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, No. 220 Handan Road, Shanghai 200433, People's Republic of China.
J Cancer Res Clin Oncol. 2008 Jun;134(6):705-14. doi: 10.1007/s00432-007-0342-6. Epub 2007 Dec 14.
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in China. Hepatocarcinogenesis is correlated with a series of gene expression alteration. Here, we investigated LAMA4 gene expression in hepatocellular carcinoma on both mRNA and protein levels, expecting to explore the relationship between expressional abundances of LAMA4 and the clinical characteristics of HCC specimens.
Total RNA was extracted from 48 cases of surgically resected HCC specimens and their corresponding peripheral tumor-free liver tissues. After the optimal reverse transcription polymerase chain reaction condition was established, the mRNA levels of LAMA4 in tumor and peripheral tumor-free tissues were examined semi-quantitatively. The relationship between expression levels of LAMA4 and clinical pathological characteristics was further analyzed by two-tailed t-test and chi2 test. We also used anti-LAMA4 antibody to detect the in vivo distribution of LAMA4 protein by tissue immunofluorescence staining in HCC specimens and their peripheral tumor-free tissues.
The expression level of LAMA4 in 48 cases of human hepatocellular carcinoma tissues was significantly higher than that in their corresponding peripheral tumor-free tissues (0.37 +/- 0.25 vs. 0.18 +/- 0.12, P < 0.01). LAMA4 gene was up-regulated in 30 (62.50%) cases of HCC, down regulated in 4 (8.33%) cases, and showed no significant changes in 14 (29.17%) cases. Analysis of relationship between LAMA4 gene expression abundances and clinical characteristics by chi2 test showed that up-regulation of LAMA4 was strongly correlated with tumor invasion (79.31%), incomplete or no envelope (75.00%) and tumor bolt (86.67%). Additionally, tissue immunofluorescence staining against LAMA4 protein detected strong signal only in HCC tissues but not their corresponding peripheral tumor-free liver tissues. To our attention, LAMA4 protein showed specific in vivo distribution along the basement membrane of tumor blood vessels, bringing insights into its potential role in tumor angiogenesis.
LAMA4 is specifically up-regulated on both mRNA and protein levels in hepatocelluar carcinoma. The strong correlation between high expression abundances of LAMA4 with tumor invasion and metastasis, as well as, LAMA4 specific in vivo distribution in tumor basement membrane, indicated LAMA4's potential role in hepatocarcinogenesis and tumor progression. Therefore, we hypothesize that LAMA4 is probably a novel supplementary marker for HCC diagnosis, and might be a molecular target in the future cancer therapy.
肝细胞癌(HCC)是中国最常见的恶性肿瘤之一。肝癌发生与一系列基因表达改变相关。在此,我们从mRNA和蛋白质水平研究了LAMA4基因在肝细胞癌中的表达,期望探索LAMA4表达丰度与HCC标本临床特征之间的关系。
从48例手术切除的HCC标本及其相应的癌旁无瘤肝组织中提取总RNA。在建立最佳逆转录聚合酶链反应条件后,半定量检测肿瘤组织和癌旁无瘤组织中LAMA4的mRNA水平。通过双尾t检验和卡方检验进一步分析LAMA4表达水平与临床病理特征之间的关系。我们还使用抗LAMA4抗体通过组织免疫荧光染色检测HCC标本及其癌旁无瘤组织中LAMA4蛋白的体内分布。
48例人肝细胞癌组织中LAMA4的表达水平显著高于其相应的癌旁无瘤组织(0.37±0.25对0.18±0.12,P<0.01)。LAMA4基因在30例(62.50%)HCC中上调,4例(8.33%)下调,14例(29.17%)无显著变化。通过卡方检验分析LAMA4基因表达丰度与临床特征之间的关系,结果显示LAMA4上调与肿瘤侵袭(79.31%)、包膜不完整或无包膜(75.00%)和癌栓(86.67%)密切相关。此外,针对LAMA4蛋白的组织免疫荧光染色仅在HCC组织中检测到强信号,而在其相应的癌旁无瘤肝组织中未检测到。值得注意的是,LAMA4蛋白在肿瘤血管基底膜上显示出特异性的体内分布,这为其在肿瘤血管生成中的潜在作用提供了线索。
LAMA4在肝细胞癌中mRNA和蛋白质水平均特异性上调。LAMA4高表达丰度与肿瘤侵袭和转移之间的强相关性,以及LAMA4在肿瘤基底膜中的特异性体内分布,表明LAMA4在肝癌发生和肿瘤进展中具有潜在作用。因此,我们推测LAMA4可能是HCC诊断的一种新型辅助标志物,并且可能是未来癌症治疗的分子靶点。